Filter Results
:
(229)
Show Results For
-
All HBS Web
(229)
- News (63)
- Research (126)
- Events (1)
- Multimedia (15)
- Faculty Publications (67)
Show Results For
-
All HBS Web
(229)
- News (63)
- Research (126)
- Events (1)
- Multimedia (15)
- Faculty Publications (67)
- February 1985 (Revised January 2024)
- Case
Health Stop (A): What Type of Innovation Is It? And Six Factors Alignment
By: Regina E. Herzlinger, Joyce Lallman, Nancy Kane, Jefferson C. Grahling and James Wallace
How can we evaluate if innovative health care ventures can do good—benefit society—and do well—become financially viable? This question is the topic of the first module in the Innovating In Health Care course book.
This note and case series enables readers to conduct...
View Details
Keywords:
For-Profit Firms;
Business Model;
Entrepreneurship;
Health Care and Treatment;
Strategy;
Valuation;
Health Industry;
Retail Industry
Herzlinger, Regina E., Joyce Lallman, Nancy Kane, Jefferson C. Grahling, and James Wallace. "Health Stop (A): What Type of Innovation Is It? And Six Factors Alignment." Harvard Business School Case 185-084, February 1985. (Revised January 2024.)
- March 2021 (Revised January 2022)
- Case
Philips: Redefining Telehealth
By: Regina E. Herzlinger, Alec Petersen, Natalie Kindred and Sara M. McKinley
As one of the world’s largest healthcare companies, Philips sought to reach beyond the walls of the hospital and expand its hospital-to-home program to gain future competitive advantage through technology solutions combining predictive analytics with care delivery. By...
View Details
Keywords:
Health Care;
Philips;
Visicu;
Telemedicine;
eICU;
Accountable Care Organization;
ACO;
Bundled Payment;
Hospital To Home;
Patient Monitoring Devices;
Home Health Care;
Health Care and Treatment;
Communication Technology;
Quality;
Safety;
Performance Productivity;
Performance Capacity;
Performance Efficiency;
Consumer Behavior;
Emerging Markets;
Health Industry;
Telecommunications Industry;
Netherlands
Herzlinger, Regina E., Alec Petersen, Natalie Kindred, and Sara M. McKinley. "Philips: Redefining Telehealth." Harvard Business School Case 321-135, March 2021. (Revised January 2022.) (As companion reading for this case, see: Regina E. Herzlinger and Charles Huang. "Note on Bundled Payment in Health Care," HBS Background Note 312-032.)
- 11 Sep 2007
- First Look
First Look: September 11, 2007
also—and crucially so—on whether or not the platforms subsidize one side of the market in equilibrium. For example, with prices being strategic complements across platforms, we show that a cost-reducing investment by one firm may have a...
View Details
Keywords:
Martha Lagace
- September 2014 (Revised March 2021)
- Case
La Ribera Health Department (A)
By: Regina E. Herzlinger, Emer Moloney and Daniela Beyersdorfer
The La Ribera case studies depict an innovative low cost/high quality privately financed hospital model struggling to achieve alignment with the Six Factors. It is reimbursed by the public sector in a Spanish environment whose Consumers, Structure, and Public Policy...
View Details
Keywords:
Health Care;
Health Care Financing;
Health Care Industry;
Health Care Operations;
Health Care and Treatment;
Operations;
Business Model;
Government and Politics;
Programs;
Innovation Strategy;
Vertical Integration;
Health Industry;
Europe;
Spain
Herzlinger, Regina E., Emer Moloney, and Daniela Beyersdorfer. "La Ribera Health Department (A)." Harvard Business School Case 315-006, September 2014. (Revised March 2021.)
- Article
Transparency as a Solution for the Hospital Capacity Problem
COVID dramatically clarified a shortcoming in our great healthcare system, but like everything in the world, it has its shortcomings. What we see through the apex of COVID is that many hospitals in hotspot areas cannot provide an adequate supply of beds. Although the...
View Details
Herzlinger, Regina E. "Transparency as a Solution for the Hospital Capacity Problem." Ohio State Law Journal 82, no. 5 (December 2021): 787–794.
- May 2018 (Revised October 2020)
- Supplement
La Ribera Health Department (B): Epilogue
By: Regina E. Herzlinger, Emer Moloney and Daniela Beyersdorfer
The La Ribera case studies depict an innovative low cost/high quality privately financed hospital model struggling to achieve alignment with the Six Factors. It is reimbursed by the public sector in a Spanish environment whose Consumers, Structure, and Public Policy...
View Details
- November 2022
- Case
The Battle Among Channels for Marketing Pharmaceuticals: UpScript, Pharmacy Benefit Managers, and Direct-to-Consumer Sales
By: Regina E. Herzlinger and Tiffany Farrell
Can an online, direct-to-consumer pharmacy both improve the quality and speed of care for patients who need branded drugs and stabilize profits for pharmaceutical manufacturers? UpScript, after years spent achieving legal and regulatory compliance and simultaneous...
View Details
Keywords:
DTC;
Internet and the Web;
Marketing Channels;
Customer Value and Value Chain;
Governing Rules, Regulations, and Reforms;
Competitive Strategy;
Service Delivery;
Growth and Development Strategy;
Pharmaceutical Industry;
Health Industry;
Retail Industry
Herzlinger, Regina E., and Tiffany Farrell. "The Battle Among Channels for Marketing Pharmaceuticals: UpScript, Pharmacy Benefit Managers, and Direct-to-Consumer Sales." Harvard Business School Case 323-031, November 2022.
- January 2008 (Revised December 2011)
- Case
Inner Mongolia Yili Group: China's Pioneering Dairy Brand
By: Regina M. Abrami, William C. Kirby, F. Warren McFarlan and Tracy Yuen Manty
Setting up the goal to become one of the top 20 enterprises in the world dairy industry by 2010, the Inner Mongolia Yili Group had ambitious plans. As one of China's biggest national dairy companies, its main challenge was competing as a local company against...
View Details
Keywords:
Global Strategy;
Globalized Markets and Industries;
Growth and Development Strategy;
Brands and Branding;
Competition;
Agriculture and Agribusiness Industry;
China
Abrami, Regina M., William C. Kirby, F. Warren McFarlan, and Tracy Yuen Manty. "Inner Mongolia Yili Group: China's Pioneering Dairy Brand." Harvard Business School Case 308-052, January 2008. (Revised December 2011.)
- March 2015 (Revised January 2024)
- Case
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen (HBS MBA ’01) hoped to win over a prominent venture capital investor for Series B financing of his firm CVI that was creating a drug-eluting balloon (DES) to treat peripheral arterial disease. As a second-mover, Duke felt he was more likely to acquire...
View Details
Keywords:
CV Ingenuity;
CVI;
Drug Eluting Balloon;
DEB;
Drug Eluting Stent;
Angioplasty Balloon;
FoxHollow;
Medical Device;
Medical Device Startup;
Premarket Approval;
PMA;
Lutonix;
Stellarex;
LEVANT;
ILLUMENATE;
Clinical Trials;
Peripheral Arterial Disease;
PAD;
Healthcare Startups;
Covidien;
Health Care and Treatment;
Health Testing and Trials;
Business Startups;
Commercialization;
Health Industry;
Medical Devices and Supplies Industry;
United States;
Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies." Harvard Business School Case 315-045, March 2015. (Revised January 2024.)
- July 1996 (Revised August 2024)
- Case
Innovative Opportunities to Manage Health Care Delivery
By: Regina E. Herzlinger and D. Scott Lurding
The purpose of this case is:
To familiarize the students with the changing landscape of health care delivery, through chains of retail medical centers and those offering value-based care (VBC).
To discuss fundamental managerial decisions about their viability...
View Details
Herzlinger, Regina E., and D. Scott Lurding. "Innovative Opportunities to Manage Health Care Delivery." Harvard Business School Case 197-011, July 1996. (Revised August 2024.)
- August 2003 (Revised August 2024)
- Case
Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment
By: Regina E. Herzlinger and John McDonough
Many health care innovations appear successful; but fail. This is the first case in the Innovating Health Care course that investigates how to create successful health care innovations. It is part of the first module in the course. This module focuses on how to...
View Details
Keywords:
Three Pillars;
Industry Analysis;
Health Care and Treatment;
Innovation and Invention;
Innovation and Management;
Medical Specialties;
Health Industry
Herzlinger, Regina E., and John McDonough. "Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment." Harvard Business School Case 304-009, August 2003. (Revised August 2024.)
- February 18, 2022
- Article
Transparency as a Solution for COVID-19 Related Hospital Capacity Issues
By: Regina E. Herzlinger and Richard Boxer
In the initial phases of the COVID-19 pandemic, many U.S. hospitals could not provide an adequate supply of beds to meet demand. Solving the problem of hospital bed capacity is of great importance in the “new normal,” which requires recognizing that SARS-CoV-2 is but...
View Details
Keywords:
COVID;
COVID-19 Pandemic;
Health Care;
Health Care Demand;
Health Care Delivery;
Health Care Industry;
Health Care Operations;
Health Care Policy;
Transparency;
Hospital;
Hospital Management;
Hospitals;
Health Pandemics;
Health Care and Treatment;
Service Delivery;
Operations;
Performance Capacity;
Policy;
Health Industry
Herzlinger, Regina E., and Richard Boxer. "Transparency as a Solution for COVID-19 Related Hospital Capacity Issues." Health Affairs Forefront (February 18, 2022).
- 2008
- Chapter
Southeast Asia and the Political Economy of Development
By: Regina M. Abrami and Richard Doner
This chapter assesses contemporary qualitative research on Southeast Asia and its contribution to the field of political economy. It focuses especially on the political origins of economic institutions and their influence on economic performance. It provides evidence...
View Details
Keywords:
Development Economics;
Entrepreneurship;
Government and Politics;
Research;
Southeast Asia
Abrami, Regina M., and Richard Doner. "Southeast Asia and the Political Economy of Development." In Southeast Asia in Political Science: Theory, Region, and Qualitative Analysis, edited by Erik Martinez Kuhonta, Dan Slater, and Tuong Vu. Stanford University Press, 2008.
- 24 Apr 2014
- News
Addressing roadblocks to innovation in health care
Innovation in health care is a national and international priority driven by demand for quality and universal access, yet it has proved very difficult to achieve. Regina E. Herzlinger, the Nancy R. McPherson...
View Details
- February 2010
- Case
Real Blue? Viagra and Intellectual Property Rights Law in China
By: Regina M. Abrami and Tracy Manty
On July 5, 2004, Pfizer's China team received disappointing news. China's patent review board just invalidated the company's existing patent on one of its most successful drugs, Viagra. Making matters worse, a Guangdong-based pharmaceutical company laid claim to...
View Details
Keywords:
Trade;
International Relations;
Patents;
Trademarks;
Lawsuits and Litigation;
Rights;
Business and Government Relations;
Pharmaceutical Industry;
China
Abrami, Regina M., and Tracy Manty. "Real Blue? Viagra and Intellectual Property Rights Law in China." Harvard Business School Case 910-409, February 2010.
- 01 Dec 2020
- News
Digital Health Care: Empowering Consumers
Regina Herzlinger, the Nancy R. McPherson Professor of Business Administration, has been studying the health care sector for nearly half a century. In that time, she has seen significant innovation in the field—and she has also seen the...
View Details
Keywords:
April White
- 25 Jan 2011
- First Look
First Look: Jan. 25
grow and become successful, they are often marked by the negative stigma associated with size and power, which elicits anticorporate sentiment from consumers. An underdog brand biography can be strategically wielded to prevent or offset...
View Details
Keywords:
Sean Silverthorne
- 10 Jul 2018
- First Look
New Research and Ideas, July 10, 2018
investors shapes information diffusion in the stock market. We exploit trade-level data to show that central brokers gather information by executing informed trades, which is then leaked to their best clients. We show that after large...
View Details
Keywords:
Dina Gerdeman
- 07 Aug 2012
- First Look
First Look: August 7
experiment to measure the value of shareholder proxy access. We find that firms that would have been most vulnerable to proxy access, as measured by institutional ownership and activist institutional ownership in particular, lost value on...
View Details
Keywords:
Sean Silverthorne
- 17 Dec 2013
- First Look
First Look: December 17
Publications August 2013 Harvard Business Review Press Can China Lead? Reaching the Limits of Power and Growth By: Abrami, Regina M., William C. Kirby, and F. Warren McFarlan Abstract—At the time of the American Revolution, China was...
View Details
Keywords:
Carmen Nobel